Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.

Kebir S, Weber M, Lazaridis L, Deuschl C, Schmidt T, Mönninghoff C, Keyvani K, Umutlu L, Pierscianek D, Forsting M, Sure U, Stuschke M, Kleinschnitz C, Scheffler B, Colletti PM, Rubello D, Rischpler C, Glas M.

Clin Nucl Med. 2018 Dec 3. doi: 10.1097/RLU.0000000000002398. [Epub ahead of print]

PMID:
30516675
2.

Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.

Nickel AC, Wan XY, Saban DV, Weng YL, Zhang S, Keyvani K, Sure U, Zhu Y.

J Neurooncol. 2018 Nov 3. doi: 10.1007/s11060-018-03017-7. [Epub ahead of print]

PMID:
30392087
3.

FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma.

Sievers P, Stichel D, Schrimpf D, Sahm F, Koelsche C, Reuss DE, Wefers AK, Reinhardt A, Huang K, Ebrahimi A, Hou Y, Pajtler KW, Pfister SM, Hasselblatt M, Stummer W, Schick U, Hartmann C, Hagel C, Staszewski O, Reifenberger G, Beschorner R, Coras R, Keyvani K, Kohlhof P, Diomedi-Camassei F, Herold-Mende C, Giangaspero F, Rushing E, Giannini C, Korshunov A, Jones DTW, von Deimling A.

Acta Neuropathol. 2018 Aug;136(2):293-302. doi: 10.1007/s00401-018-1882-3. Epub 2018 Jul 5.

PMID:
29978331
4.

Aβ dimers induce behavioral and neurochemical deficits of relevance to early Alzheimer's disease.

Abdel-Hafiz L, Müller-Schiffmann A, Korth C, Fazari B, Chao OY, Nikolaus S, Schäble S, Herring A, Keyvani K, Lamounier-Zepter V, Huston JP, de Souza Silva MA.

Neurobiol Aging. 2018 Sep;69:1-9. doi: 10.1016/j.neurobiolaging.2018.04.005. Epub 2018 Apr 17.

PMID:
29803148
5.

Higher levels of kallikrein-8 in female brain may increase the risk for Alzheimer's disease.

Keyvani K, Münster Y, Kurapati NK, Rubach S, Schönborn A, Kocakavuk E, Karout M, Hammesfahr P, Wang YC, Hermann DM, Teuber-Hanselmann S, Herring A.

Brain Pathol. 2018 Nov;28(6):947-964. doi: 10.1111/bpa.12599. Epub 2018 Apr 10.

PMID:
29505099
6.

Repeated Systemic Treatment with Rapamycin Affects Behavior and Amygdala Protein Expression in Rats.

Hadamitzky M, Herring A, Kirchhof J, Bendix I, Haight MJ, Keyvani K, Lückemann L, Unteroberdörster M, Schedlowski M.

Int J Neuropsychopharmacol. 2018 Jun 1;21(6):592-602. doi: 10.1093/ijnp/pyy017.

7.

Association of primary central nervous system vasculitis with the presence of specific human leucocyte antigen gene variant.

Kraemer M, Becker J, Horn PA, Schwitalla JC, Keyvani K, Metz I, Wegner C, Brück W, Schlamann M, Heinemann FM, Berlit P.

Clin Neurol Neurosurg. 2017 Sep;160:137-141. doi: 10.1016/j.clineuro.2017.06.009. Epub 2017 Jun 23.

PMID:
28734234
8.

Response letter.

Keyvani K.

Alzheimers Dement. 2017 Sep;13(9):1070-1071. doi: 10.1016/j.jalz.2017.06.003. Epub 2017 Jul 8. No abstract available.

PMID:
28692820
9.

EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.

You C, Zhao K, Dammann P, Keyvani K, Kreitschmann-Andermahr I, Sure U, Zhu Y.

J Cell Mol Med. 2017 Sep;21(9):1848-1858. doi: 10.1111/jcmm.13105. Epub 2017 Apr 1.

10.

Primary central nervous system vasculitis and its mimicking diseases - clinical features, outcome, comorbidities and diagnostic results - A case control study.

Becker J, Horn PA, Keyvani K, Metz I, Wegner C, Brück W, Heinemann FM, Schwitalla JC, Berlit P, Kraemer M.

Clin Neurol Neurosurg. 2017 May;156:48-54. doi: 10.1016/j.clineuro.2017.03.006. Epub 2017 Mar 8.

PMID:
28324788
11.

Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical course.

Heß K, Purrucker J, Hegenbart U, Brokinkel B, Berndt R, Keyvani K, Monoranu CM, Löhr M, Reifenberger G, Munoz-Bendix C, Kalla J, Groß J, Schick U, Kollmer J, Klapper W, Röcken C, Hasselblatt M, Paulus W.

Brain Pathol. 2018 Mar;28(2):234-239. doi: 10.1111/bpa.12493. Epub 2017 Mar 13.

PMID:
28160367
12.

The multi-target effects of CNI-1493: convergence of anti-amylodogenic and anti-inflammatory properties in animal models of Alzheimer's disease.

Sankowski R, Herring A, Keyvani K, Frenzel K, Wu J, Röskam S, Noelker C, Bacher M, Al-Abed Y.

Mol Med. 2016 Dec;22:776-788. doi: 10.2119/molmed.2016.00163. Epub 2016 Nov 15.

13.

Study of angiogenic signaling pathways in hemangioblastoma.

Pierscianek D, Wolf S, Keyvani K, El Hindy N, Stein KP, Sandalcioglu IE, Sure U, Mueller O, Zhu Y.

Neuropathology. 2017 Feb;37(1):3-11. doi: 10.1111/neup.12316. Epub 2016 Jul 7.

PMID:
27388534
14.

Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice.

Herring A, Münster Y, Akkaya T, Moghaddam S, Deinsberger K, Meyer J, Zahel J, Sanchez-Mendoza E, Wang Y, Hermann DM, Arzberger T, Teuber-Hanselmann S, Keyvani K.

Alzheimers Dement. 2016 Dec;12(12):1273-1287. doi: 10.1016/j.jalz.2016.05.006. Epub 2016 Jun 18.

15.

Late running is not too late against Alzheimer's pathology.

Herring A, Münster Y, Metzdorf J, Bolczek B, Krüssel S, Krieter D, Yavuz I, Karim F, Roggendorf C, Stang A, Wang Y, Hermann DM, Teuber-Hanselmann S, Keyvani K.

Neurobiol Dis. 2016 Oct;94:44-54. doi: 10.1016/j.nbd.2016.06.003. Epub 2016 Jun 14.

PMID:
27312772
16.

Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.

Hasselblatt M, Thomas C, Hovestadt V, Schrimpf D, Johann P, Bens S, Oyen F, Peetz-Dienhart S, Crede Y, Wefers A, Vogel H, Riemenschneider MJ, Antonelli M, Giangaspero F, Bernardo MC, Giannini C, Ud Din N, Perry A, Keyvani K, van Landeghem F, Sumerauer D, Hauser P, Capper D, Korshunov A, Jones DT, Pfister SM, Schneppenheim R, Siebert R, Frühwald MC, Kool M.

Acta Neuropathol. 2016 Jul;132(1):149-51. doi: 10.1007/s00401-016-1574-9. Epub 2016 Apr 11. No abstract available.

PMID:
27067307
17.

Activation of multiple angiogenic signaling pathways in hemangiopericytoma.

Pierscianek D, Michel A, Hindy NE, Keyvani K, Dammann P, Oezkan N, Mueller O, Sure U, Zhu Y.

Brain Tumor Pathol. 2016 Jul;33(3):200-8. doi: 10.1007/s10014-016-0256-6. Epub 2016 Mar 7.

PMID:
26951238
18.

Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups.

Thomas C, Sill M, Ruland V, Witten A, Hartung S, Kordes U, Jeibmann A, Beschorner R, Keyvani K, Bergmann M, Mittelbronn M, Pietsch T, Felsberg J, Monoranu CM, Varlet P, Hauser P, Olar A, Grundy RG, Wolff JE, Korshunov A, Jones DT, Bewerunge-Hudler M, Hovestadt V, von Deimling A, Pfister SM, Paulus W, Capper D, Hasselblatt M.

Neuro Oncol. 2016 Jun;18(6):790-6. doi: 10.1093/neuonc/nov322. Epub 2016 Jan 28.

19.

Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.

Müller-Schiffmann A, Herring A, Abdel-Hafiz L, Chepkova AN, Schäble S, Wedel D, Horn AH, Sticht H, de Souza Silva MA, Gottmann K, Sergeeva OA, Huston JP, Keyvani K, Korth C.

Brain. 2016 Feb;139(Pt 2):509-25. doi: 10.1093/brain/awv355. Epub 2015 Dec 10.

PMID:
26657517
20.

Recurrent Bacterial Meningitis Perpetuated by an Infected Rathke's Cleft Cyst.

Berlit P, Keyvani K, Herring A, Krämer M.

Fortschr Neurol Psychiatr. 2015 Oct;83(10):e14-6. doi: 10.1055/s-0041-108098. Epub 2015 Nov 23.

PMID:
26595231
21.

[Cerebral amyloid angiopathy and dementia].

Berlit P, Keyvani K, Krämer M, Weber R.

Nervenarzt. 2015 Oct;86(10):1248-54. doi: 10.1007/s00115-015-4407-5. Review. German.

PMID:
26384105
22.

Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.

Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, Poppiti RJ, Bockelman B, Keyvani K, Pollak L, Mendlovic S, Fowkes M, Eberhart CG, Buttmann M, Toyka KV, Meyer-ter-Vehn T, Petursdottir V, Gilden D.

JAMA Neurol. 2015 Nov;72(11):1281-7. doi: 10.1001/jamaneurol.2015.2101.

23.

Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.

Zhu Y, Zhao K, Prinz A, Keyvani K, Lambertz N, Kreitschmann-Andermahr I, Lei T, Sure U.

Neuro Oncol. 2016 Apr;18(4):538-48. doi: 10.1093/neuonc/nov155. Epub 2015 Aug 8.

24.

Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.

Metz I, Traffehn S, Straßburger-Krogias K, Keyvani K, Bergmann M, Nolte K, Weber MS, Bartsch T, Gold R, Brück W.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 2;2(3):e99. doi: 10.1212/NXI.0000000000000099. eCollection 2015 Jun. No abstract available. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2015 Jun;2(3):e116.

25.

Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.

Gilden D, White T, Khmeleva N, Heintzman A, Choe A, Boyer PJ, Grose C, Carpenter JE, Rempel A, Bos N, Kandasamy B, Lear-Kaul K, Holmes DB, Bennett JL, Cohrs RJ, Mahalingam R, Mandava N, Eberhart CG, Bockelman B, Poppiti RJ, Tamhankar MA, Fogt F, Amato M, Wood E, Durairaj V, Rasmussen S, Petursdottir V, Pollak L, Mendlovic S, Chatelain D, Keyvani K, Brueck W, Nagel MA.

Neurology. 2015 May 12;84(19):1948-55. doi: 10.1212/WNL.0000000000001409. Epub 2015 Feb 18.

26.

Cerebral toxoplasmosis in an adolescent post allogeneic hematopoietic stem cell transplantation: successful outcome by antiprotozoal chemotherapy and CD4+ T-lymphocyte recovery.

Kerl K, Ehlert K, Brentrup A, Schiborr M, Keyvani K, Becker K, Rossig C, Groll AH.

Transpl Infect Dis. 2015 Feb;17(1):119-24. doi: 10.1111/tid.12344. Epub 2015 Jan 12.

PMID:
25581774
27.

Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid.

Fritschi SK, Langer F, Kaeser SA, Maia LF, Portelius E, Pinotsi D, Kaminski CF, Winkler DT, Maetzler W, Keyvani K, Spitzer P, Wiltfang J, Kaminski Schierle GS, Zetterberg H, Staufenbiel M, Jucker M.

Brain. 2014 Nov;137(Pt 11):2909-2915. doi: 10.1093/brain/awu255. Epub 2014 Sep 10.

28.

Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.

Ohta T, Kim YH, Oh JE, Satomi K, Nonoguchi N, Keyvani K, Pierscianek D, Sure U, Mittelbronn M, Paulus W, Vital A, Yokoo H, McDonald K, Kleihues P, Nazaret N, Barbet F, Lachuer J, Ohgaki H.

J Neuropathol Exp Neurol. 2014 Oct;73(10):908-15. doi: 10.1097/NEN.0000000000000110.

PMID:
25192052
29.

Acute systemic rapamycin induces neurobehavioral alterations in rats.

Hadamitzky M, Herring A, Keyvani K, Doenlen R, Krügel U, Bösche K, Orlowski K, Engler H, Schedlowski M.

Behav Brain Res. 2014 Oct 15;273:16-22. doi: 10.1016/j.bbr.2014.06.056. Epub 2014 Jul 17.

PMID:
25043732
30.

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.

Wiestler B, Capper D, Hovestadt V, Sill M, Jones DT, Hartmann C, Felsberg J, Platten M, Feiden W, Keyvani K, Pfister SM, Wiestler OD, Meyermann R, Reifenberger G, Pietsch T, von Deimling A, Weller M, Wick W.

Neuro Oncol. 2014 Dec;16(12):1630-8. doi: 10.1093/neuonc/nou138. Epub 2014 Jul 15.

31.

Predictive chromosomal clusters of synchronous and metachronous brain metastases in clear cell renal cell carcinoma.

Gutenberg A, Nischwitz MD, Gunawan B, Enders C, Jung K, Bergmann M, Feiden W, Egensperger R, Keyvani K, Stolke D, Sure U, Schroeder HW, Warzok R, Schober R, Meixensberger J, Paulus W, Wassmann H, Stummer W, Blumcke I, Buchfelder M, van Landeghem FK, Vajkoczy P, Günther M, Bedke J, Giese A, Rohde V, Brück W, Füzesi L, Sander B.

Cancer Genet. 2014 May;207(5):206-13. doi: 10.1016/j.cancergen.2014.05.004. Epub 2014 May 17.

PMID:
25027636
32.

Increased mitotic and proliferative activity are associated with worse prognosis in papillary tumors of the pineal region.

Heim S, Beschorner R, Mittelbronn M, Keyvani K, Riemenschneider MJ, Vajtai I, Hartmann C, Acker T, Blümcke I, Paulus W, Hasselblatt M.

Am J Surg Pathol. 2014 Jan;38(1):106-10. doi: 10.1097/PAS.0b013e31829e492d.

PMID:
24121176
33.

Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme.

El Hindy N, Keyvani K, Pagenstecher A, Dammann P, Sandalcioglu IE, Sure U, Zhu Y.

Neuro Oncol. 2013 Oct;15(10):1366-78. doi: 10.1093/neuonc/not071. Epub 2013 Jun 20.

34.

[Biopsy diagnosis in neurology].

Koelble K, Herring A, Keyvani K.

Fortschr Neurol Psychiatr. 2013 Apr;81(4):210-27; quiz 228-9. doi: 10.1055/s-0032-1330526. Epub 2013 Apr 15. Review. German. No abstract available.

PMID:
23589114
35.

Expression of aquaporin 5 and the AQP5 polymorphism A(-1364)C in association with peritumoral brain edema in meningioma patients.

Lambertz N, Hindy NE, Adler C, Rump K, Adamzik M, Keyvani K, Bankfalvi A, Siffert W, Erol Sandalcioglu I, Bachmann HS.

J Neurooncol. 2013 Apr;112(2):297-305. doi: 10.1007/s11060-013-1064-z. Epub 2013 Feb 8.

PMID:
23392848
36.

PDGFRA gain in low-grade diffuse gliomas.

Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Nonoguchi N, Pierscianek D, Kim YH, Mariani L, Vital A, Perry A, Ohgaki H.

J Neuropathol Exp Neurol. 2013 Jan;72(1):61-6. doi: 10.1097/NEN.0b013e31827c4b5b.

PMID:
23242283
37.

Lack of MGMT promoter hypermethylation in hemangiopericytomas of the central nervous system.

Brokinkel B, Peetz-Dienhart S, Keyvani K, Stummer W, Paulus W, Hasselblatt M.

J Neurooncol. 2012 Nov;110(2):303-4. doi: 10.1007/s11060-012-0967-4. Epub 2012 Aug 23. No abstract available.

PMID:
22915192
38.

DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.

Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Pierscianek D, Kim YH, Mariani L, Vital A, Ohgaki H.

J Neuropathol Exp Neurol. 2012 Aug;71(8):702-7.

PMID:
22805772
39.

MET gain in diffuse astrocytomas is associated with poorer outcome.

Pierscianek D, Kim YH, Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Wrede K, Nakazato Y, Tanaka Y, Mariani L, Vital A, Sure U, Ohgaki H.

Brain Pathol. 2013 Jan;23(1):13-8. doi: 10.1111/j.1750-3639.2012.00609.x. Epub 2012 Jul 3.

PMID:
22672415
40.

Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss.

Kim YH, Nonoguchi N, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Mariani L, Giangaspero F, Tanaka Y, Nakazato Y, Vital A, Mittelbronn M, Perry A, Ohgaki H.

Brain Pathol. 2012 Nov;22(6):834-40. doi: 10.1111/j.1750-3639.2012.00601.x. Epub 2012 Jun 1.

PMID:
22568401
41.

Reelin depletion is an early phenomenon of Alzheimer's pathology.

Herring A, Donath A, Steiner KM, Widera MP, Hamzehian S, Kanakis D, Kölble K, ElAli A, Hermann DM, Paulus W, Keyvani K.

J Alzheimers Dis. 2012;30(4):963-79. doi: 10.3233/JAD-2012-112069.

PMID:
22495348
42.

Exercise during pregnancy mitigates Alzheimer-like pathology in mouse offspring.

Herring A, Donath A, Yarmolenko M, Uslar E, Conzen C, Kanakis D, Bosma C, Worm K, Paulus W, Keyvani K.

FASEB J. 2012 Jan;26(1):117-28. doi: 10.1096/fj.11-193193. Epub 2011 Sep 24.

PMID:
21948247
43.

Circulating extracellular proteasome in the cerebrospinal fluid: a study on concentration and proteolytic activity.

Mueller O, Anlasik T, Wiedemann J, Thomassen J, Wohlschlaeger J, Hagel V, Keyvani K, Schwieger I, Dahlmann B, Sure U, Sixt SU.

J Mol Neurosci. 2012 Mar;46(3):509-15. doi: 10.1007/s12031-011-9631-2. Epub 2011 Sep 1.

PMID:
21881828
44.

Brain-reactive β-amyloid antibodies in primary CNS angiitis with cerebral amyloid angiopathy.

Hermann DM, Keyvani K, van de Nes J, Weimar C, Wiltfang J, Nitsch RM, Szodorai A.

Neurology. 2011 Aug 2;77(5):503-5. doi: 10.1212/WNL.0b013e318227b250. Epub 2011 Jul 20. No abstract available.

PMID:
21775736
45.

Very late and isolated leptomeningeal relapse of a pulmonary adenocarcinoma presenting as dementia.

Christoph DC, Wittkowski L, Stattaus J, Pöttgen C, Keyvani K, Gauler TC, Schuler M, Eberhardt WE.

Onkologie. 2011;34(6):316-20. doi: 10.1159/000328765. Epub 2011 May 17. No abstract available.

PMID:
21625185
46.

Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study.

Kastrup O, van de Nes J, Gasser T, Keyvani K.

J Neurol. 2011 Dec;258(12):2140-6. doi: 10.1007/s00415-011-6071-4. Epub 2011 May 10.

PMID:
21556878
47.

Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.

Dodel R, Balakrishnan K, Keyvani K, Deuster O, Neff F, Andrei-Selmer LC, Röskam S, Stüer C, Al-Abed Y, Noelker C, Balzer-Geldsetzer M, Oertel W, Du Y, Bacher M.

J Neurosci. 2011 Apr 13;31(15):5847-54. doi: 10.1523/JNEUROSCI.4401-10.2011.

48.

Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations.

Kim YH, Lachuer J, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nobusawa S, Nakazato Y, Tanaka Y, Vital A, Mariani L, Ohgaki H.

Brain Pathol. 2011 Nov;21(6):645-51. doi: 10.1111/j.1750-3639.2011.00492.x. Epub 2011 May 30.

PMID:
21470325
49.

Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms.

Herring A, Lewejohann L, Panzer AL, Donath A, Kröll O, Sachser N, Paulus W, Keyvani K.

Neurobiol Dis. 2011 Jun;42(3):530-8. doi: 10.1016/j.nbd.2011.03.007. Epub 2011 Mar 22.

PMID:
21406231
50.

Triad of visual, auditory and corticospinal tract lesions: a new syndrome in a patient with HIV infection.

Kleffner I, Wersching H, Schwindt W, Kuhlmann T, Keyvani K, Deppe M, Husstedt I.

AIDS. 2011 Mar 13;25(5):659-63. doi: 10.1097/QAD.0b013e328342fc05.

PMID:
21252633

Supplemental Content

Loading ...
Support Center